Private Equity

Private Equity Law360 provides breaking news and analysis on private equity deals and the attorneys involved. Coverage includes high-impact deals, related litigation and enforcement actions, and policy developments that affect private equity firms.



Sign up for a 7-day FREE trial today!



Latest News in Private Equity

  • October 09, 2026

    Warren Presses Fed For Details Of Early SVB Report Access

    The U.S. Senate Banking Committee's top Democrat is calling on Federal Reserve officials for answers after some outside experts were given an early look at a recent independent report on Silicon Valley Bank's collapse, questioning who authorized the access and how recipients were chosen.

  • October 09, 2026

    Iberdrola Loses Bid To Revive Mass. Power Plant Fraud Suit

    A New York appellate court has declined to revive an Iberdrola unit's lawsuit accusing the funders of a Massachusetts power plant project of tricking the energy company into largely completing construction before interfering in the contract to avoid funding the work.

  • October 09, 2026

    TRex Bio Leads 2 Drugmakers Pricing IPOs Totaling $162M

    Two clinical-stage biotechnology firms, TRex Bio and Retension Pharmaceuticals, hit the public markets on Friday after raising a combined $162 million in their initial public offerings.

  • October 09, 2026

    Latham-Led Consonance Clinches $1.35B Healthcare Fund

    Latham & Watkins LLP-advised healthcare private equity shop Consonance Capital Partners on Friday revealed that it closed its latest fund with $1.35 billion of investor commitments.

  • October 09, 2026

    SEC Proposes Restoring Funds' Ability To Cross-Trade Bonds

    The U.S. Securities and Exchange Commission put forth a proposal on Friday to make it easier for mutual and other registered funds under the same manager to trade with one another, while promising to update the oversight rules for fund managers participating in such cross-trades.

See more Private Equity news

Private Equity

Areas of Coverage

  • TRANSACTIONS
  • Private equity deals valued at $50MM or more
  • Venture capital investments of $25MM or more
  • Mergers and acquisitions
  • Capital investments, including mezzanine and growth capital deals
  • Joint ventures involving private equity firms
  • Hostile takeovers and leveraged buyouts
  • Distressed investment deals
  • AGENCIES
  • U.S. Commodity Futures Trading Commission
  • Federal Trade Commission
  • Financial Industry Regulatory Authority
  • Public Company Accounting Oversight Board
  • U.S. Department of Justice
  • U.S. Department of the Treasury
  • U.S. Securities and Exchange Commission
  • International competition and securities regulators
  • POLICY & REGULATION
  • Dodd-Frank Act
  • Delaware corporate law
  • Antitrust and consumer protection controls
  • Private equity industry lobbying
  • International banking legislation and regulation
  • ENFORCEMENT
  • Merger reviews
  • Second requests
  • Challenges and divestitures
  • Litigation
  • Antitrust suits
  • Shareholder disputes
  • Corporate governance fights
  • Poison pill challenges
  • Hostile takeover disputes
  • Privacy and consumer protection suits
  • Bankruptcy proceedings involving private equity stakeholders
  • PROFILES
  • Personnel moves
  • Profiles of private equity practices

Readership

  • Private equity lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the private equity industry
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals